Common pathology of ACS

Ischaemic heart disease is a complex process which develops over a number of years. A number of changes can be seen:
- Initial endothelial dysfunction is triggered by a number of factors such as smoking, hypertension and hyperglycaemia
- A number of changes to the endothelium including pro-inflammatory, pro-oxidant, proliferative and reduced nitric oxide bioavailability
- Fatty infiltration of the subendothelial space by low-density lipoprotein (LDL) particles
- Monocytes migrate from the blood and differentiate into macrophages.
- These macrophages then phagocytose oxidized LDL, slowly turning into large 'foam cells'.
- As these macrophages die the result can further propagate the inflammatory process.
- Smooth muscle proliferation and migration from the tunica media into the intima results in formation of a fibrous capsule covering the fatty plaque.
Summary
- Atheromatous plaque formation in coronary arteries
- Fissuring/ulceration of the plaque
- Leads to platelet aggregation
- Localised thrombosis, vasoconstriction and distal thromboembolism
- Leads to myocardial ischaemia
- Death in IHD is usually due to VF: ventricular fibrillation
This can occur in areas of low-grade stenosis which have not previously caused angina-type symptoms
Unstable angina (crescendo angina)
- Angina occurring at rest OR sudden increased frequency/severity of existing angina